Health
Hims & Hers Adds Longtime Novo Executive to Board Amid Weight-Loss Bet
This article is for subscribers only.
Hims & Hers Health Inc. is adding longtime Novo Nordisk A/S executive Kåre Schultz to its board of directors after its move into the booming market for weight-loss drugs.
Schultz, who spent over 25 years at Novo, said in an interview that Hims has a “long future” in selling so-called compounded versions of blockbuster weight-loss drugs like Wegovy and Zepbound.